
(© Rainer Hendla | Dreamstime.com)
Quiet Workspaces Did Not Help Kids With ADHD, Trial Finds
In A Nutshell
- Four common classroom accommodations showed no measurable benefit for 255 kids with ADHD.
- Medication cut seatwork rule-breaking by 61%, and behavior therapy by 37%.
- A moderate medication dose worked and may be enough for many kids.
- Results need confirming in everyday classrooms.
Extra time on tests, standing desks, quiet workspaces, and frequent breaks did not help kids with ADHD behave better or do better in class, a major clinical trial found. Estimates suggest up to half of students with ADHD receive school help through a formal plan, either an individualized education program (IEP) or a 504 plan, and those plans typically include supports like these.
Researchers tested four of those accommodations against stimulant medication and a behavior therapy classroom setup, then reported the results in JAMA Pediatrics. Medication cut rule-breaking during independent seatwork by 61% and raised quiz scores by nearly four percentage points on a 100-point scale. Behavior therapy cut seatwork rule-breaking by 37%.
How well accommodations work, the authors point out, has been understudied, and no systematic study had examined them alongside medication and behavior therapy. Extra time and a quiet corner sound like common-sense fixes, which may be why they are so easy to take for granted. That leaves parents and educators with a pointed question: are these supports doing what they are meant to do?
Medication Outperformed ADHD Accommodations in the Same 255 Children
Children in kindergarten through sixth grade, all diagnosed with ADHD, were recruited at two sites, one in the southeastern and one in the northeastern United States, over four summers from 2022 to 2025. Of 306 children screened, 280 enrolled, 255 started, and 235 finished, and data from all 255 starters were analyzed. About 79% were boys. Caregivers identified roughly 74% as white, 19% as Black, and 51% as Hispanic or Latino, with some children counted in more than one group.
Rather than comparing a treatment group with a separate comparison group, the trial used a crossover design. Every child went through every condition at different times, so each child served as their own comparison and differences between kids did not muddy the results. Everything took place in a summer treatment program, where a teacher and an aide ran two one-hour classes each day, one for independent seatwork and one for a group lesson followed by a 10-question quiz.
Three kinds of help were mixed and matched. One was medication: kids switched weekly between a placebo and a moderate dose of a stimulant medication approved for ADHD, in opaque capsules that kept kids and staff from knowing which was which. Another was classroom management. Kids spent two-week blocks in either a standard classroom or an enhanced one with a daily report card scoring personal behavior goals, frequent praise, and earned free time.
Accommodations were the third piece. Each day, kids were randomly assigned none or one of four: 45 minutes instead of 30 for seatwork, short breaks, noise-canceling headphones with a desk divider, or the option to stand while working. Researchers tracked rule violations, such as talking back to an adult, along with correctly solved seatwork problems and quiz scores.
Extended Time and Other ADHD Accommodations Showed No Significant Gains
Not one of the four accommodations measurably improved rule-following, seatwork, or quiz scores. Some nudged results the wrong way. Extra time was linked to 11% fewer correctly finished seatwork problems per minute, the biggest dip, though the authors call the dips small. The other three showed smaller dips or none. Adding accommodations to medication or behavior therapy produced no extra benefit either. Why they fell flat was not tested. One reasonable guess is that these supports change the setting without changing a child’s motivation to stay on task, which rewards and medication target more directly.
A Moderate Medication Dose and Behavior Therapy Both Delivered Results
Medication also raised the rate of correct seatwork answers by 22%. Behavior therapy did little for academics, leaving quiz scores essentially unchanged, but it curbed misbehavior in group lessons as well as seatwork. According to the authors, the approach required no added cost or staff time in the study, and its pieces could reasonably be carried out in a regular classroom.
Medication worked at a moderate dose, 0.3 milligrams per kilogram of body weight, even though some current recommendations favor the highest dose a child can tolerate. Few children stopped treatment over side effects, and the authors say a moderate dose may be enough for many kids, citing risks tied to long-term high doses. The trial tested only that one dose, so it could not compare dose levels directly.
Parents heading into an IEP or 504 meeting have a fair question to ask: what evidence backs the supports being offered? The trial does not show that accommodations never help any child. It tested four of them in a summer program, and the authors say the work needs replication in everyday classrooms. Still, until accommodations show gains of their own, the authors argue, medication and behavior therapy deserve more emphasis in school plans.
Disclaimer: This article summarizes one study and is not medical advice. Families should consult a child’s doctor and school team before changing any treatment or school plan.
Paper Notes
Limitations
Authors note that the summer treatment program suits controlled testing, but results need to be checked in everyday school classrooms, where treatments are typically carried out less rigorously and effects would likely be weaker rather than stronger. Kids varied in how they used the accommodations, and accommodations changed daily instead of being used consistently, which may have affected results. Individual differences based on neuropsychological profiles might change how well accommodations work for specific children, a question the authors say a companion report addresses. The study ran only during the summer, and research spanning a full school year could add useful information. The trial also measured daily classroom behavior, seatwork, and quiz performance, so it cannot say whether accommodations affect longer-term school success. It tested four accommodations, one medication at one dose, and a sample that was about 79% boys.
Funding and Disclosures
Funding came from grant R01HD105318, awarded to Florida International University by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The Children’s Trust funded part of the infrastructure for the summer treatment program in Miami. The funders had no role in the study’s design, conduct, data analysis, manuscript preparation, or the decision to submit it for publication, and the authors say the content does not necessarily reflect the official views of the National Institutes of Health. Dr. Gregory A. Fabiano reported receiving royalties from Guilford Press during the conduct of the study. No other disclosures were reported.
Publication Details
Titled “Attention-Deficit/Hyperactivity Disorder Accommodations, Behavior Therapy, and Stimulant Medication: A Randomized Clinical Trial,” the paper was written by Gregory A. Fabiano, PhD; Brittany M. Merrill, PhD; Rosalia F. Gallo, PhD; Marcela Ramos, PhD; Morgan Jusko, PhD; Devon Tower, MA; Elizabeth M. Gnagy, MA; Amy Boeckel, MA; Jennifer Piscitello, PhD; Maya Renaud, BA; Alyssa Dawson, BA; Jennifer Sikov, MA; Carolina Ramirez, MA; Grant C. Edmondson, BA; Michael S. Adragna, MD; Carlos A. Salgado, MD; and Timothy B. Hayes, PhD. The paper lists all authors except Adragna with Florida International University (Amherst, New York) and Adragna with the University at Buffalo. It was accepted October 13, 2026, and published online November 13, 2026, in JAMA Pediatrics (doi:10.1001/jamapediatrics.2026.5973). The corresponding author is Gregory A. Fabiano. The trial is registered at ClinicalTrials.gov under identifier NCT05469386.







